RFL · Insider Trading
Rafael Holdings, Inc. Class B Common Stock
Every open-market purchase and sale reported by RFL officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-23 | David Polinsky | Chief Financial Officer | F | −2,027 | −$4.10K |
| 2026-07-31 | Howard S Jonas | Exec Chairman, CEO & President | A | +54,945 | +$150.00K |
| 2026-06-23 | David Polinsky | Chief Financial Officer | F | −2,386 | −$6.29K |
| 2026-06-16 | Howard S Jonas | Exec Chairman, CEO & President | MIXED | +134,071 | +$229.53K |
| 2026-03-24 | David Polinsky | Chief Financial Officer | F | −2,318 | −$2.96K |
| 2026-03-17 | Howard S Jonas | Exec Chairman, CEO & President | F | −9,826 | −$14.76K |
| 2026-01-30 | Markus Sieger | Director | A | +29,528 | +$37.50K |
| 2026-01-29 | Michael J Weiss | Director | A | +39,370 | +$50.00K |
| 2026-01-29 | Mark N Stein | Director | A | +39,370 | +$50.00K |
| 2026-01-29 | Alan Grayson | Director | A | +6,562 | +$8.33K |
| 2026-01-15 | David Polinsky | Chief Financial Officer | MIXED | +45,135 | +$56.35K |
| 2026-01-15 | Howard S Jonas | Exec Chairman, CEO & President | A | +75,000 | +$93.64K |
| 2025-12-23 | David Polinsky | Chief Financial Officer | F | −1,961 | −$2.52K |
| 2025-12-16 | Howard S Jonas | Exec Chairman, CEO & President | F | −9,867 | −$14.78K |
| 2025-03-25 | David Polinsky | Chief Financial Officer | F | −2,378 | −$4.59K |
| 2025-03-25 | William Conkling | Chief Executive Officer | F | −14,814 | −$28.59K |
| 2025-01-15 | John Goldberg | CHIEF MEDICAL OFFICER | A | +50,000 | +$97.70K |
| 2025-01-15 | David Polinsky | Chief Financial Officer | A | +50,000 | +$97.70K |
| 2025-01-15 | William Conkling | Chief Executive Officer | A | +60,000 | +$117.24K |
| 2025-01-08 | Stephen M Greenberg | Director | A | +27,541 | +$50.12K |
| 2025-01-08 | Mark N Stein | Director | A | +11,475 | +$20.88K |
| 2025-01-08 | Michael J Weiss | Director | A | +27,541 | +$50.12K |
| 2024-12-23 | David Polinsky | Chief Financial Officer | F | −2,002 | −$3.67K |
| 2024-12-23 | William Conkling | Chief Executive Officer | F | −12,807 | −$23.50K |
| 2024-10-29 | William Conkling | Chief Executive Officer | F | −3,431 | −$6.31K |
| 2024-10-29 | David Polinsky | Chief Financial Officer | F | −3,331 | −$6.13K |
| 2024-09-24 | William Conkling | Chief Executive Officer | F | −12,696 | −$21.90K |
| 2024-09-24 | David Polinsky | Chief Financial Officer | F | −3,815 | −$6.58K |
| 2024-07-26 | Howard S Jonas | Executive Chairman | J | — | — |
| 2024-06-28 | Howard S Jonas | Executive Chairman | J | — | — |
| 2024-06-25 | William Conkling | Chief Executive Officer | F | −13,295 | −$19.34K |
| 2024-06-25 | David Polinsky | Chief Financial Officer | F | −2,296 | −$3.34K |
| 2024-06-17 | Howard S Jonas | Executive Chairman | MIXED | +159,016 | — |
| 2024-04-08 | Howard S Jonas | Executive Chairman | J | — | — |
| 2024-03-25 | William Conkling | Chief Executive Officer | F | +15,473 | +$26.38K |
| 2024-03-25 | David Polinsky | Chief Financial Officer | F | −2,300 | −$3.92K |
| 2024-02-01 | Howard S Jonas | Executive Chairman | J | — | — |
| 2024-01-18 | John Goldberg | CHIEF MEDICAL OFFICER | A | +250,000 deriv. | — |
| 2024-01-08 | Mark Anthony McCamish | Director | A | +27,655 | +$50.06K |
| 2024-01-08 | Stephen M Greenberg | Director | A | +27,655 | +$50.06K |
| 2024-01-08 | Michael J Weiss | Director | A | +27,655 | +$50.06K |
| 2023-12-26 | William Conkling | Chief Executive Officer | F | +13,602 | +$24.76K |
| 2023-12-26 | David Polinsky | Chief Financial Officer | F | −8,577 | −$15.61K |
| 2023-10-26 | David Polinsky | Chief Financial Officer | A | +40,000 | +$60.60K |
| 2023-10-26 | William Conkling | Chief Executive Officer | A | +40,000 | +$60.60K |
| 2023-09-26 | David Polinsky | Chief Financial Officer | F | −2,541 | −$5.17K |
| 2023-09-22 | William Conkling | Chief Executive Officer | F | −13,669 | −$30.14K |
| 2023-08-30 | Howard S Jonas | Executive Chairman | A | +111,408 | +$250.00K |
| 2023-08-01 | Howard S Jonas | Executive Chairman | J | +787,163 | — |
| 2023-06-22 | William Conkling | Chief Executive Officer | F | −15,170 | −$32.62K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Howard S Jonas | Exec Chairman, CEO & President | 610,850 | $772.73K |
| William Conkling | Chief Executive Officer | 537,001 | $679.31K |
| David Polinsky | Chief Financial Officer | 297,084 | $375.81K |
| Markus Sieger | Director | 219,710 | $277.93K |
| Michael J Weiss | Director | 141,861 | $179.45K |
| Stephen M Greenberg | Director | 102,491 | $129.65K |
| Mark N Stein | Director | 50,845 | $64.32K |
| John Goldberg | CHIEF MEDICAL OFFICER | 50,000 | $63.25K |
| Alan Grayson | Director | 6,562 | $8.30K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the RFL quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.